Register for OBR daily

To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

NYMX $1.62 0.6300 +63.64%
ONCY $0.87 0.1100 +14.47%
DRNA $22.03 2.7600 +14.32%
TLOG $4.66 0.5800 +14.22%
MEIP $2.39 0.2700 +12.74%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

CALA $16.16 -2.2100 -12.03%
ENZN $1.16 -0.1300 -10.08%
KITE $58.68 -6.3800 -9.81%
NKTR $10.96 -0.9900 -8.28%
ZIOP $10.96 -0.9600 -8.06%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | Next > | Last >>

Meet the Facebook for Doctors

(CNBC) Apr 8, 2015 - Sermo - a "Facebook for doctors" - helps physicians connect with specialists. For one doctor, the service helped his cancer patient survive.
read article 

Longtime Mayo Clinic Executive Joins Scripps Cancer Care Program

(Scripps) Apr 8, 2015 - Longtime Mayo Clinic executive Karen Jensen has joined Scripps Health as director of the oncology clinical care line for the health system’s integrated cancer program.
read press release 

Florida Cancer Specialists’ Physician Named FLASCO President

(FCS) Apr 13, 2015 - Florida Cancer Specialists & Research Institute (FCS) is pleased to announce that Michael Diaz, MD, who serves on the FCS Executive Board, has been named President of the Florida Society of Clinical Oncology (FLASCO) at the organization’s Spring Conference and Annual Meeting, held last week in Orlando, FL.
read press release 

Memorial Sloan Kettering Opens Pediatric CAR T Cell Clinical Trial

(MSKCC) Apr 9, 2015 - Researchers from Memorial Sloan Kettering Cancer Center (MSK) are pioneering a new groundbreaking clinical trial for children and young adults with relapsed or treatment-resistant acute lymphocytic leukemia (ALL) by using one of the most promising methods of cancer treatment today, chimeric antigen receptor (CAR) T cells.
read press release 

Cologuard® Receives Coverage by Several Commercial Health Plans in Q1 2015

(Yahoo! Finance) Apr 13, 2015 - Exact Sciences Corp. today announced expanded patient access to Cologuard as a result of several insurers now covering the test. Cologuard is now covered for more than 90 million Medicare and commercial lives across the U.S.
read article 

Take Action to Decrease Your Cancer Risk - Obesity and Its Role in Cancer Health Disparities

(NCI) Apr 10, 2015 - In support of this year’s National Minority Health Month “Prevention is Power: Taking Action for Health Equity!”, the NCI Center to Reduce Cancer Health Disparities (CRCHD) is highlighting the role of obesity in cancer health disparities among diverse population groups in the U.S.
read article 

Why Survival Rate Is Not the Best Way to Judge Cancer Spending

(New York Times/The Upshot blog) Apr 13, 2015 - For many cancers in the United States, we’ve made little headway in mortality rates, which is a different measure altogether.
read article 

Protocol Trumps Logic: Prostate Cancer MRI Request Denied

(Forbes) Apr 10, 2015 - Last Friday, my partner wanted to get an MRI for his prostate cancer patient. This may seem like a simple task.
read article 

How the Hottest Biotech Sprouted in Iowa

(Wall Street Journal) Apr 12, 2015 - NewLink’s focus on one of the hottest areas of cancer treatment—immunotherapy—has attracted interest from one of the industry’s most respected R&D shops: Roche Holding AG’s Genentech unit.
read article (paid subscription required) 

Medivir Links with CRT to Develop New Cancer Drugs

(PharmaTimes [UK]) Apr 13, 2015 - Swedish biotech Medivir and Cancer Research Technology have unveiled plans to work on a new class of drugs that has shown promise for a range of different cancers, including more aggressive types.
read article 

Roche Strengthens Oncology Translational Research Pipeline by Acquiring CAPP Medical

(CNNMoney) Apr 13, 2015 - Roche today announced it has acquired CAPP Medical, a genomics research company founded by Stanford University oncologists and industry veterans, to advance the development of technology for cancer screening and monitoring through the detection of circulating tumor DNA (ctDNA) in blood.
read article 

Drug Development Showcasing at AACR Conference

(Pharmafile [UK]) Apr 13, 2015 - Roche’s biotech subsidiary Genentech, along with Novartis, AstraZeneca and Bayer will all present data on investigational treatments, in special sessions on drug development highlighting new cancer drugs on the horizon.
read article 

AstraZeneca to Showcase Strong Oncology Science at American Association for Cancer Research Annual Meeting 2015

( Apr 13, 2015 - AstraZeneca will present new data at the American Association for Cancer Research (AACR) annual meeting in Philadelphia this weekend, demonstrating the strength and depth of its early stage oncology pipeline.
read article 

Study Finds Cancer Link for Muscle-building Supplements

(Brown University) Apr 13, 2015 — Men who reported taking muscle-building supplements, such as pills and powders with creatine or androstenedione, reported a significantly higher likelihood of having developed testicular cancer than men who did not use such supplements, according to a new study in the British Journal of Cancer.
read article 

Healthy Elders May Hold Key to Fighting Cancer

(University of California) Apr 8, 2015 - Could the immune systems of healthy seniors hold clues for beating the most aggressive form of breast cancer?
read article 

New Low-temperature Plasma Treatment for Prostate Cancer Developed

(Medical News Today) Apr 12, 2015 - Researchers from the University of York in the UK have discovered a potential new treatment option for patients with early-stage prostate cancer - low-temperature plasmas.
read article 

Researchers Find Protein That May Signal More Aggressive Prostate Cancers

(University of Michigan) Apr 13, 2015 - University of Michigan researchers have discovered a biomarker that may be a potentially important breakthrough in diagnosing and treating prostate cancer.
read press release 

Why Some Doctors Are Hesitant To Screen Smokers For Lung Cancer

(NPR/Shots blog) Apr 13, 2015 - As more and more people are getting screened for lung cancer, some doctors worry the test is doing more harm than good.
read article 

Study Backs HPV Vaccine for Boys

(Toronto Star) Apr 13, 2015 - Vaccinating boys against the human papillomavirus could help reduce throat cancers and save millions, says study in journal Cancer.
read article 

Aetna, Cigna Balk as Angelina Effect Spurs Genetic Cancer Testing

(Reuters) Apr 12, 2015 - Major insurance companies including Aetna, Anthem and Cigna are declining to pay for the latest generation of tests, known as multi-gene panel tests, Reuters has learned. The insurers say that the tests are unproven and may lead patients to seek out medical care they don't need.
read article 

FDA Panel Wary of Dropping Warnings From Tobacco Pouch

(ABC News/Associated Press) Apr 10, 2015 - The eight-member panel voted unanimously that the company's application does not show that snus lack the same risks of gum diseases and tooth loss as other smokeless tobacco products.
read article 

PhRMA and LLS Report More Than 240 Medicines in Development to Treat Leukemia, Lymphoma and Other Blood Cancers

( Apr 10, 2015 - America's biopharmaceutical research companies are currently developing more than 240 medicines for leukemia, lymphoma, myeloma and other forms of blood cancer, including more targeted treatment options for patients.
read press release 

Large Variation in Payments Seen in Oncology Practice

(Medscape Medical News) Apr 10, 2015 - Annual payments for key services delivered to Medicare beneficiaries treated in individual oncology practices vary widely, particularly chemotherapy.
read article (free registration required) 

Pfizer Accused of Knowing Zoloft Posed Birth-Defect Risk

(Bloomberg) Apr 9, 2015 - Pfizer Inc. researchers concluded last year that pregnant women taking Zoloft risked having babies with heart defects, according to evidence made public by a lawyer at the first trial of more than 1,000 lawsuits over the drug.
read article 

Data Suggests AstraZeneca Drug May Increase Death Rate

(Reuters) Apr 10, 2015 - AstraZeneca Plc's diabetes drug Onglyza may be associated with an increased rate of death, according to a preliminary review of data by the U.S. Food and Drug Administration.
read article